drugset / Trial / NCT01095588

Study the Effect of Avanafil on the Pharmacodynamics and Pharmacokinetics of Warfarin in Healthy Male Subjects

NCT01095588

Phase 1 Completed 24 enrolled VIVUS LLC
RandomizedCrossoverDouble-blindTreatment

Summary

This study is designed to look into the effect of avanafil on blood levels of warfarin and to investigate its effect on prothrombin time/international normalized ratio (INR) in healthy men.

Timeline

Start
2010-04
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Avanafil Small molecule 200 mg

Indications